Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 50010256
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536857(CHEMBL4581663)
Affinity DataIC50: 15nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536857(CHEMBL4581663)
Affinity DataIC50: 57nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536833(CHEMBL4546760)
Affinity DataIC50: 60nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536838(CHEMBL4520267)
Affinity DataIC50: 73nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536838(CHEMBL4520267)
Affinity DataIC50: 80nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCalpain-1/Calpain-2 catalytic subunit(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536838(CHEMBL4520267)
Affinity DataIC50: 96nMAssay Description:Inhibition of calpain (unknown origin) using calpain substrate preincubated for 20 mins followed by substrate addition by fluorescence plate reader a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536833(CHEMBL4546760)
Affinity DataIC50: 110nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536856(CHEMBL4520585)
Affinity DataIC50: 130nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536844(CHEMBL4553669)
Affinity DataIC50: 190nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCathepsin B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536838(CHEMBL4520267)
Affinity DataIC50: 200nMAssay Description:Inhibition of recombinant human cathepsin B (332 residues) expressed in CHO cells using Z-FR-AMC as substrate preincubated for 20 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536856(CHEMBL4520585)
Affinity DataIC50: 210nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536844(CHEMBL4553669)
Affinity DataIC50: 230nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536845(CHEMBL4567870)
Affinity DataIC50: 270nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCathepsin B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536839(CHEMBL2402203 | acs.jmedchem.1c00409_ST.724)
Affinity DataIC50: 300nMAssay Description:Inhibition of recombinant human cathepsin B (332 residues) expressed in CHO cells using Z-FR-AMC as substrate preincubated for 20 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536845(CHEMBL4567870)
Affinity DataIC50: 530nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCalpain-1/Calpain-2 catalytic subunit(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 600nMAssay Description:Inhibition of calpain (unknown origin) using calpain substrate preincubated for 20 mins followed by substrate addition by fluorescence plate reader a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCalpain-1/Calpain-2 catalytic subunit(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536839(CHEMBL2402203 | acs.jmedchem.1c00409_ST.724)
Affinity DataIC50: 600nMAssay Description:Inhibition of calpain (unknown origin) using calpain substrate preincubated for 20 mins followed by substrate addition by fluorescence plate reader a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCathepsin B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 700nMAssay Description:Inhibition of recombinant human cathepsin B (332 residues) expressed in CHO cells using Z-FR-AMC as substrate preincubated for 20 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536858(CHEMBL4578571)
Affinity DataIC50: 720nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536849(CHEMBL4574173)
Affinity DataIC50: 920nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536836(CHEMBL4579064)
Affinity DataIC50: 950nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536836(CHEMBL4579064)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536862(CHEMBL4588146)
Affinity DataIC50: 1.01E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536847(CHEMBL4535723)
Affinity DataIC50: 1.04E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536846(CHEMBL4567655)
Affinity DataIC50: 1.08E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536851(CHEMBL4539211)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536837(CHEMBL4572200)
Affinity DataIC50: 1.13E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536846(CHEMBL4567655)
Affinity DataIC50: 1.19E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536837(CHEMBL4572200)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of full length N-terminal His6-tagged ATG4B (unknown origin) expressed in Escherichia coli BL21(DE3) cells using His-GATE-16-GST as substr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.21E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536862(CHEMBL4588146)
Affinity DataIC50: 1.27E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536837(CHEMBL4572200)
Affinity DataIC50: 1.47E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536847(CHEMBL4535723)
Affinity DataIC50: 1.76E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536851(CHEMBL4539211)
Affinity DataIC50: 1.78E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536848(CHEMBL4569375)
Affinity DataIC50: 1.86E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536832(CHEMBL4562540)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 2.57E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536858(CHEMBL4578571)
Affinity DataIC50: 2.99E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536867(CHEMBL4554009)
Affinity DataIC50: 3.61E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536849(CHEMBL4574173)
Affinity DataIC50: 3.76E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536848(CHEMBL4569375)
Affinity DataIC50: 4.06E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536850(CHEMBL4570064)
Affinity DataIC50: 4.12E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536832(CHEMBL4562540)
Affinity DataIC50: 4.47E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536843(CHEMBL4566679)
Affinity DataIC50: 4.79E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536839(CHEMBL2402203 | acs.jmedchem.1c00409_ST.724)
Affinity DataIC50: 5.09E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536850(CHEMBL4570064)
Affinity DataIC50: 5.68E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536866(CHEMBL4525169)
Affinity DataIC50: 6.48E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536860(CHEMBL4527514)
Affinity DataIC50: 9.13E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536859(CHEMBL4540188)
Affinity DataIC50: 1.17E+4nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536866(CHEMBL4525169)
Affinity DataIC50: 1.23E+4nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: